SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE

Scope & Guideline

Connecting researchers to elevate HIV treatment and understanding.

Introduction

Immerse yourself in the scholarly insights of SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1608-9693
PublisherAOSIS
Support Open AccessYes
CountrySouth Africa
TypeJournal
Convergefrom 2001 to 2024
AbbreviationS AFR J HIV MED / South. Afr. J. HIV Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPostnet Suite 110, Private Bag x 19, Durbanville 7550, SOUTH AFRICA

Aims and Scopes

The Southern African Journal of HIV Medicine focuses on advancing knowledge and practice in the field of HIV medicine, with a particular emphasis on the Southern African context. It aims to disseminate research that informs clinical practice, public health strategies, and policy decisions related to HIV management and treatment.
  1. HIV Treatment and Management:
    The journal covers various aspects of antiretroviral therapy (ART), including the efficacy of different drug regimens, management of treatment failures, and the impact of ART on comorbidities.
  2. Public Health and Epidemiology:
    Research related to the epidemiology of HIV, including incidence rates, risk factors, and public health interventions aimed at reducing transmission and improving health outcomes.
  3. Paediatric HIV Care:
    Focus on the unique challenges and approaches in managing HIV in children, including treatment strategies, adherence issues, and the impact of HIV on child development.
  4. Socioeconomic and Psychological Factors:
    Investigating how social determinants, mental health, and support systems affect the health outcomes of individuals living with HIV.
  5. Guidelines and Policy Development:
    The journal plays a crucial role in formulating and updating clinical guidelines that inform healthcare professionals and policymakers on best practices in HIV care.
  6. Innovative Interventions and Technologies:
    Exploration of new methods for HIV prevention, diagnosis, and treatment, including digital health technologies and community-based interventions.
The Southern African Journal of HIV Medicine has highlighted several emerging themes and trends in HIV research, reflecting current challenges and advancements in the field. These trends indicate where the focus of research is shifting and the areas that are gaining importance.
  1. Integrated Care Models:
    There is an increasing emphasis on multidisciplinary approaches that integrate HIV care with other health services, addressing the comprehensive needs of patients.
  2. Impact of COVID-19 on HIV Services:
    Research examining the effects of the COVID-19 pandemic on HIV testing, treatment adherence, and overall healthcare delivery has gained prominence, emphasizing resilience in healthcare systems.
  3. Community-Based Interventions:
    There is a rising interest in community-led initiatives and peer support programs that enhance access to HIV services and improve health outcomes.
  4. Long-Acting Antiretroviral Therapies:
    Studies focusing on long-acting injectable therapies and their implications for improving adherence and reducing stigma are becoming more common.
  5. Mental Health and HIV:
    Research exploring the intersection of mental health issues and HIV is increasingly relevant, reflecting a broader understanding of the psychosocial aspects of living with HIV.
  6. Pre-Exposure Prophylaxis (PrEP) Uptake:
    There is a growing body of work addressing the barriers and facilitators to PrEP uptake, particularly in high-risk populations, which is crucial for HIV prevention strategies.

Declining or Waning

While the journal continues to cover a broad spectrum of HIV-related topics, certain areas have shown a decline in publication frequency. This may reflect shifting priorities in HIV research or the evolving landscape of HIV medicine.
  1. Traditional Virology Studies:
    Research focused solely on the virology of HIV without integrating clinical or public health implications has seen a decrease, as the field moves towards more multidisciplinary approaches.
  2. Single-Country Focused Studies:
    Studies concentrating exclusively on HIV issues in a single country have diminished in favor of comparative or regional studies that can provide broader insights.
  3. Basic Science Research:
    Research that primarily addresses basic science aspects of HIV, such as laboratory-based virology without clinical application, appears to be less emphasized in recent publications.
  4. Non-HIV Related Comorbidities:
    While comorbidities related to HIV are still relevant, the focus on conditions that are not directly linked to HIV or its treatment has decreased, reflecting a shift towards more integrated and relevant clinical research.

Similar Journals

AIDS PATIENT CARE AND STDS

Pioneering research for better patient care.
Publisher: MARY ANN LIEBERT, INCISSN: 1087-2914Frequency: 12 issues/year

Welcome to AIDS PATIENT CARE AND STDS, a leading journal dedicated to the comprehensive exploration of clinical practices, research advancements, and public health strategies centered around HIV/AIDS and sexually transmitted diseases. Published by Mary Ann Liebert, Inc., this esteemed journal has been at the forefront of disseminating critical findings since 1996, contributing to a robust understanding of the complexities surrounding these global health issues. With an impressive impact factor reflected in its 2023 Q1 quartile rankings in both Infectious Diseases and Public Health, Environmental and Occupational Health, the journal stands out among its peers, ranking at the 95th percentile for Public Health and 91st percentile in Infectious Diseases. Researchers, healthcare professionals, and students will benefit from its rich content, comprehensive studies, and critical reviews that aim to improve care practices and health outcomes. With a clear commitment to fostering knowledge and collaboration in the field, AIDS PATIENT CARE AND STDS is an essential resource for those dedicated to combating these pressing health challenges.

ANNALS OF INTERNAL MEDICINE

Pioneering Research for a Healthier Tomorrow
Publisher: AMER COLL PHYSICIANSISSN: 0003-4819Frequency: 12 issues/year

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

Journal of the International AIDS Society

Enhancing Understanding, Improving Health Outcomes
Publisher: JOHN WILEY & SONS LTDISSN: Frequency: 12 issues/year

The Journal of the International AIDS Society, published by John Wiley & Sons Ltd, stands as a premier platform for advancing knowledge in the realms of infectious diseases and public health, boasting a strong Q1 ranking in both categories as of 2023. With its open-access format established since 2004, the journal ensures that groundbreaking research on HIV/AIDS and related issues is widely disseminated and easily accessible to a global audience. This commitment to accessibility significantly enhances its impact factor, making it a vital resource for researchers, practitioners, and students alike who are dedicated to improving health outcomes and understanding the complexities of the epidemic. Covering a diverse range of topics from prevention strategies to health policy, the journal supports its readers in staying at the forefront of public health discourse. With its base in the United States and an impressive Scopus ranking placing it within the top tiers of medical publications, the Journal of the International AIDS Society continues to foster collaboration and innovation in the fight against HIV/AIDS.

AIDS RESEARCH AND HUMAN RETROVIRUSES

Exploring Innovative Solutions for HIV Challenges
Publisher: MARY ANN LIEBERT, INCISSN: 0889-2229Frequency: 12 issues/year

AIDS RESEARCH AND HUMAN RETROVIRUSES, published by Mary Ann Liebert, Inc., is a pivotal journal dedicated to advancing the field of HIV research and the broader spectrum of human retroviruses. With an ISSN of 0889-2229 and an E-ISSN of 1931-8405, this journal has been in continuous publication since 1987 and is respected in the academic community for its rigorous peer-reviewed articles. As a Q3 ranked journal in Immunology, Infectious Diseases, and Virology as of 2023, it plays a crucial role in disseminating cutting-edge research, theoretical advancements, and clinical insights that contribute significantly to the understanding and treatment of HIV and related disorders. The journal's objective is to foster collaboration among researchers, healthcare professionals, and educators by providing a platform for the exchange of innovative ideas and findings. Although not an open-access journal, its compelling content ensures that it remains a primary resource for those in the academic and medical communities tackling the challenges posed by retroviral infections. With a commitment to excellence and relevance, AIDS RESEARCH AND HUMAN RETROVIRUSES continues to shape the future of research in this critical area.

AJAR-African Journal of AIDS Research

Uniting Voices for Effective HIV/AIDS Solutions
Publisher: TAYLOR & FRANCIS LTDISSN: 1608-5906Frequency: 4 issues/year

AJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.

JOURNAL OF MEDICAL VIROLOGY

Connecting Science and Practice: Insights for Clinicians and Researchers.
Publisher: WILEYISSN: 0146-6615Frequency: 12 issues/year

JOURNAL OF MEDICAL VIROLOGY is a prestigious academic publication dedicated to advancing the field of virology and infectious diseases. Published by WILEY, this journal has established itself as a cornerstone within the scientific community since its inception in 1977, and it will continue to provide cutting-edge research until 2024. With an impressive impact factor that places it in the Q1 quartile for both Infectious Diseases and Virology, the journal ranks 14 out of 344 in Medicine - Infectious Diseases and 6 out of 80 in Immunology and Microbiology - Virology according to Scopus metrics. Its focus encompasses a broad spectrum of topics, including viral pathogenesis, diagnostics, treatment strategies, and epidemiology, making it an essential resource for researchers, clinicians, and students alike. Although not an open-access journal, it provides valuable insights and accessible content for subscribers and libraries. The ongoing commitment to high-quality peer-reviewed articles makes JOURNAL OF MEDICAL VIROLOGY a vital platform for disseminating knowledge and fostering innovation in virology and related fields.

Journal of the International Association of Providers of AIDS Care

Empowering Providers with Cutting-Edge Research
Publisher: SAGE PUBLICATIONS INCISSN: 2325-9574Frequency: 1 issue/year

Journal of the International Association of Providers of AIDS Care, published by SAGE PUBLICATIONS INC, is a distinguished open-access journal dedicated to the field of HIV/AIDS care and research. Since its inception in 2002, the journal has provided an essential platform for the dissemination of high-quality, peer-reviewed scholarly articles that advance knowledge in exciting areas such as dermatology, immunology, and infectious diseases. With an impact factor that highlights its role in shaping ongoing discourse, the journal boasts a strong reputation, reflected in its Q1 status in Dermatology and consistent ranking in the top tiers for immunology and infectious diseases in the Scopus Ranks. This commitment to excellence ensures that researchers, healthcare professionals, and students have access to the latest advancements and best practices in HIV/AIDS prevention and care. As a pivotal resource in the global health landscape, the journal stands at the forefront of efforts to combat the challenges presented by this ongoing epidemic.

AIDS Research and Therapy

Exploring innovative therapies for a global challenge.
Publisher: BMCISSN: 1742-6405Frequency: 1 issue/year

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.

AIDS Research and Treatment

Pioneering insights in HIV/AIDS care.
Publisher: HINDAWI LTDISSN: 2090-1240Frequency: 1 issue/year

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

Southern African Journal of Gynaecological Oncology

Connecting researchers to enhance women's health outcomes.
Publisher: MEDPHARM PUBLICATIONS PTY LTDISSN: 2074-2835Frequency: 2 issues/year

The Southern African Journal of Gynaecological Oncology, published by MEDPHARM PUBLICATIONS PTY LTD, is a leading open-access journal that has been at the forefront of disseminating critical research in the field of gynecological oncology since its inception in 2009. With an ISSN of 2074-2835 and an E-ISSN of 2220-105X, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the nuanced complexities of women's health, particularly in the context of Southern Africa. The journal is dedicated to promoting innovative findings and clinical practices to enhance patient care in gynecological cancer treatment and prevention. Its open-access model ensures that high-quality, peer-reviewed research is readily available to a global audience, fostering collaboration and knowledge sharing within the academic community. As the journal continues to grow, it emphasizes the importance of addressing regional health challenges and advancing the discourse in gynecological oncology.